Somerset Trust’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.97M Buy
9,282
+44
+0.5% +$8.63K 0.56% 52
2026
Q1
$1.81M Buy
9,238
+127
+1% +$24.7K 0.56% 53
2025
Q4
$1.58M Buy
9,111
+29
+0.3% +$5.28K 0.48% 58
2025
Q3
$1.73M Sell
9,082
-150
-2% -$26.6K 0.53% 54
2025
Q2
$1.66M Sell
9,232
-128
-1% -$22.2K 0.54% 53
2025
Q1
$1.58M Sell
9,360
-92
-1% -$15.1K 0.56% 49
2024
Q4
$1.43M Sell
9,452
-16
-0.2% -$2.49K 0.54% 52
2024
Q3
$1.47M Sell
9,468
-2
-0% -$299 0.55% 51
2024
Q2
$1.3M Sell
9,470
-48
-0.5% -$6.57K 0.53% 49
2024
Q1
$1.27M Sell
9,518
-147
-2% -$19.1K 0.52% 50
2023
Q4
$1.33M Sell
9,665
-250
-3% -$32.9K 0.58% 48
2023
Q3
$1.21M Sell
9,915
-213
-2% -$28.4K 0.55% 47
2023
Q2
$1.42M Sell
10,128
-796
-7% -$110K 0.61% 47
2023
Q1
$1.55M Sell
10,924
-322
-3% -$46.1K 0.67% 47
2022
Q4
$1.76M Sell
11,246
-33
-0.3% -$4.74K 0.74% 47
2022
Q3
$1.38M Sell
11,279
-161
-1% -$21.2K 0.64% 47
2022
Q2
$1.52M Buy
11,440
+1
+0% +$136 0.67% 48
2022
Q1
$1.57M Sell
11,439
-453
-4% -$63.1K 0.61% 52
2021
Q4
$2.06M Buy
11,892
+16
+0.1% +$2.43K 0.75% 47
2021
Q3
$1.73M Sell
11,876
-333
-3% -$48.7K 0.7% 51
2021
Q2
$1.61M Buy
12,209
+2
+0% +$262 0.66% 52
2021
Q1
$1.57M Sell
12,207
-38
-0.3% -$4.68K 0.68% 52
2020
Q4
$1.46M Sell
12,245
-62
-0.5% -$7.56K 0.66% 49
2020
Q3
$1.41M Sell
12,307
-40
-0.3% -$4.73K 0.71% 48
2020
Q2
$1.41M Sell
12,347
-23
-0.2% -$2.44K 0.75% 50
2020
Q1
$993K Sell
12,370
-1,902
-13% -$197K 0.65% 51
2019
Q4
$1.52M Sell
14,272
-246
-2% -$25.7K 0.75% 53
2019
Q3
$1.55M Sell
14,518
-2,493
-15% -$256K 0.82% 51
2019
Q2
$1.73M Sell
17,011
-242
-1% -$23.3K 0.89% 46
2019
Q1
$1.55M Hold
17,253
0.82% 49
2018
Q4
$1.44M Sell
17,253
-251
-1% -$23.5K 0.84% 49
2018
Q3
$1.89M Sell
17,504
-44
-0.3% -$4.83K 0.93% 41
2018
Q2
$1.93M Sell
17,548
-1,166
-6% -$121K 1.04% 35
2018
Q1
$1.88M Sell
18,714
-203
-1% -$20.8K 0.97% 38
2017
Q4
$1.86M Sell
18,917
-5,620
-23% -$533K 0.93% 43
2017
Q3
$2.3M Sell
24,537
-1,453
-6% -$154K 1.22% 21
2017
Q2
$2.89M Sell
25,990
-222
-0.8% -$23.5K 1.57% 13
2017
Q1
$2.57M Sell
26,212
-493
-2% -$47K 1.44% 16
2016
Q4
$2.45M Sell
26,705
-779
-3% -$67.1K 1.45% 16
2016
Q3
$2.33M Sell
27,484
-5,429
-16% -$456K 1.39% 16
2016
Q2
$2.68M Buy
32,913
+5,504
+20% +$419K 1.65% 11
2016
Q1
$1.96M Sell
27,409
-126
-0.5% -$8.45K 1.3% 16
2015
Q4
$1.96M Buy
27,535
+7,465
+37% +$502K 1.29% 17
2015
Q3
$1.23M Buy
20,070
+147
+0.7% +$10.3K 0.87% 38
2015
Q2
$1.45M Hold
19,923
0.95% 33
2015
Q1
$1.53M Buy
+19,923
New +$1.43M 1.01% 28

Other funds holding DGX

Somerset Trust's DGX Position: Q2 2026 in Review

Somerset Trust increased its Quest Diagnostics (DGX) stake by 0.48% in Q2 2026, buying an estimated $8.63K and bringing the position to 9,282 shares worth $1.97M. The position accounts for 0.56% of the portfolio, ranked #52.

Somerset Trust first reported a position in DGX in Q1 2015 and has held it in 46 quarters since. The position peaked at $2.89M in Q2 2017. 152 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Somerset Trust held 9,282 shares of Quest Diagnostics worth $1.97M as of Q2 2026.
  • Somerset Trust bought 44 Quest Diagnostics shares in Q2 2026, an estimated $8.63K.
  • Quest Diagnostics made up 0.56% of Somerset Trust's portfolio in Q2 2026, its #52 holding.
  • Somerset Trust first reported a position in Quest Diagnostics in Q1 2015 and has held it in 46 quarters since.
  • Somerset Trust's Quest Diagnostics position peaked at $2.89M in Q2 2017.
  • 152 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Somerset Trust's 13F filing for Q2 2026, filed 6 Jul 2026.